BIOMAT Database Logo BIOMAT Database Logo

Ceestatin, a novel small molecule inhibitor of hepatitis C virus replication, inhibits 3-hydroxy-3-methylglutaryl-coenzyme A synthase. 2011

Lee F Peng, and Esperance A K Schaefer, and Nicole Maloof, and Andrew Skaff, and Andrew Berical, and Craig A Belon, and Julie A Heck, and Wenyu Lin, and David N Frick, and Todd M Allen, and Henry M Miziorko, and Stuart L Schreiber, and Raymond T Chung
Gastrointestinal Unit, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.

BACKGROUND Hepatitis C virus (HCV) chronically infects >170 million persons worldwide and is a leading cause of cirrhosis and hepatocellular carcinoma. The identification of more effective and better-tolerated agents for treating HCV is a high priority. We have reported elsewhere the discovery of the anti-HCV compound ceestatin using a high-throughput screen of a small molecule library. METHODS To identify host or viral protein targets in an unbiased fashion, we performed affinity chromatography, using tandem liquid chromatography/mass spectrometry to identify specific potential targets. RESULTS. Ceestatin binds to 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) synthase and irreversibly inhibits HMG-CoA synthase in a dose-dependent manner. Ceestatin's anti-HCV effects are reversed by addition of HMG-CoA, mevalonic acid, or geranylgeraniol. Treatment with small interfering RNA against HMG-CoA synthase led to a substantial reduction in HCV replication, further validating HMG-CoA synthase as an enzyme essential for HCV replication. CONCLUSIONS Ceestatin therefore exerts its anti-HCV effects through inhibition of HMG-CoA synthase. It may prove useful as an antiviral agent, as a probe to study HCV replication, and as a cholesterol-lowering agent. The logical stepwise process employed to discover the mechanism of action of ceestatin can serve as a general experimental strategy to uncover the targets on which novel uncharacterized anti-HCV compounds act.

UI MeSH Term Description Entries
D007783 Lactones Cyclic esters of hydroxy carboxylic acids, containing a 1-oxacycloalkan-2-one structure. Large cyclic lactones of over a dozen atoms are MACROLIDES. Lactone
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002846 Chromatography, Affinity A chromatographic technique that utilizes the ability of biological molecules, often ANTIBODIES, to bind to certain ligands specifically and reversibly. It is used in protein biochemistry. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Chromatography, Bioaffinity,Immunochromatography,Affinity Chromatography,Bioaffinity Chromatography
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006904 Hydroxymethylglutaryl-CoA Synthase An enzyme that catalyzes the synthesis of hydroxymethylglutaryl-CoA from acetyl-CoA and acetoacetyl-CoA. This is a key enzyme in steroid biosynthesis. This enzyme was formerly listed as EC 4.1.3.5. HMG CoA Synthase,3-hydroxy-3-methylglutaryl-coenzyme A synthase,HMG-CoA synthase,3 hydroxy 3 methylglutaryl coenzyme A synthase,A synthase, 3-hydroxy-3-methylglutaryl-coenzyme,CoA Synthase, HMG,Hydroxymethylglutaryl CoA Synthase,Synthase, HMG CoA,Synthase, Hydroxymethylglutaryl-CoA,synthase, 3-hydroxy-3-methylglutaryl-coenzyme A,synthase, HMG-CoA
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013058 Mass Spectrometry An analytical method used in determining the identity of a chemical based on its mass using mass analyzers/mass spectrometers. Mass Spectroscopy,Spectrometry, Mass,Spectroscopy, Mass,Spectrum Analysis, Mass,Analysis, Mass Spectrum,Mass Spectrum Analysis,Analyses, Mass Spectrum,Mass Spectrum Analyses,Spectrum Analyses, Mass
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D016174 Hepacivirus A genus of FLAVIVIRIDAE causing parenterally-transmitted HEPATITIS C which is associated with transfusions and drug abuse. Hepatitis C virus is the type species. Hepatitis C virus,Hepatitis C-Like Viruses,Hepaciviruses,Hepatitis C Like Viruses,Hepatitis C viruses,Hepatitis C-Like Virus

Related Publications

Lee F Peng, and Esperance A K Schaefer, and Nicole Maloof, and Andrew Skaff, and Andrew Berical, and Craig A Belon, and Julie A Heck, and Wenyu Lin, and David N Frick, and Todd M Allen, and Henry M Miziorko, and Stuart L Schreiber, and Raymond T Chung
F-244 specifically inhibits 3-hydroxy-3-methylglutaryl coenzyme A synthase.
December 1987, Biochimica et biophysica acta,
Lee F Peng, and Esperance A K Schaefer, and Nicole Maloof, and Andrew Skaff, and Andrew Berical, and Craig A Belon, and Julie A Heck, and Wenyu Lin, and David N Frick, and Todd M Allen, and Henry M Miziorko, and Stuart L Schreiber, and Raymond T Chung
Substrate stereochemistry of 3-hydroxy-3-methylglutaryl-coenzyme A synthase.
March 1974, European journal of biochemistry,
Lee F Peng, and Esperance A K Schaefer, and Nicole Maloof, and Andrew Skaff, and Andrew Berical, and Craig A Belon, and Julie A Heck, and Wenyu Lin, and David N Frick, and Todd M Allen, and Henry M Miziorko, and Stuart L Schreiber, and Raymond T Chung
Coordinate regulation of cholesterol synthesis and 3-hydroxy-3-methylglutaryl coenzyme A synthase but not 3-hydroxy-3-methylglutaryl coenzyme A reductase in C-6 glia.
November 1981, Archives of biochemistry and biophysics,
Lee F Peng, and Esperance A K Schaefer, and Nicole Maloof, and Andrew Skaff, and Andrew Berical, and Craig A Belon, and Julie A Heck, and Wenyu Lin, and David N Frick, and Todd M Allen, and Henry M Miziorko, and Stuart L Schreiber, and Raymond T Chung
Hepatic mitochondrial 3-hydroxy-3-methylglutaryl-coenzyme a synthase deficiency.
September 1998, Pediatric research,
Lee F Peng, and Esperance A K Schaefer, and Nicole Maloof, and Andrew Skaff, and Andrew Berical, and Craig A Belon, and Julie A Heck, and Wenyu Lin, and David N Frick, and Todd M Allen, and Henry M Miziorko, and Stuart L Schreiber, and Raymond T Chung
Trapping of a novel coenzyme A containing intermediate of 3-hydroxy-3-methylglutaryl-CoA synthase.
March 1976, Biochemical and biophysical research communications,
Lee F Peng, and Esperance A K Schaefer, and Nicole Maloof, and Andrew Skaff, and Andrew Berical, and Craig A Belon, and Julie A Heck, and Wenyu Lin, and David N Frick, and Todd M Allen, and Henry M Miziorko, and Stuart L Schreiber, and Raymond T Chung
A novel small molecule inhibitor of hepatitis C virus entry.
September 2010, PLoS pathogens,
Lee F Peng, and Esperance A K Schaefer, and Nicole Maloof, and Andrew Skaff, and Andrew Berical, and Craig A Belon, and Julie A Heck, and Wenyu Lin, and David N Frick, and Todd M Allen, and Henry M Miziorko, and Stuart L Schreiber, and Raymond T Chung
Pharmacological profile of a novel synthetic inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
August 1997, Arzneimittel-Forschung,
Lee F Peng, and Esperance A K Schaefer, and Nicole Maloof, and Andrew Skaff, and Andrew Berical, and Craig A Belon, and Julie A Heck, and Wenyu Lin, and David N Frick, and Todd M Allen, and Henry M Miziorko, and Stuart L Schreiber, and Raymond T Chung
Direct vascular effects of HR780, a novel 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.
December 2003, Clinical and experimental pharmacology & physiology,
Lee F Peng, and Esperance A K Schaefer, and Nicole Maloof, and Andrew Skaff, and Andrew Berical, and Craig A Belon, and Julie A Heck, and Wenyu Lin, and David N Frick, and Todd M Allen, and Henry M Miziorko, and Stuart L Schreiber, and Raymond T Chung
Bleomycin is a potent small-molecule inhibitor of hepatitis C virus replication.
September 2006, Chembiochem : a European journal of chemical biology,
Lee F Peng, and Esperance A K Schaefer, and Nicole Maloof, and Andrew Skaff, and Andrew Berical, and Craig A Belon, and Julie A Heck, and Wenyu Lin, and David N Frick, and Todd M Allen, and Henry M Miziorko, and Stuart L Schreiber, and Raymond T Chung
Identification of AP80978, a novel small-molecule inhibitor of hepatitis C virus replication that targets NS4B.
June 2014, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!